Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
31st Jan 20185:12 pmRNSTotal Voting Rights
29th Jan 20182:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20185:05 pmRNSPublication of Suppl.Prospcts
29th Dec 20171:20 pmRNSDirector/PDMR Shareholding
29th Dec 20171:20 pmRNSTotal Voting Rights
21st Dec 201710:14 amRNSSegmental Reporting Restatement Document
21st Dec 20179:00 amRNSDirectorate Change
7th Dec 20175:23 pmRNSPublication of a Prospectus
30th Nov 20173:29 pmRNSTotal Voting Rights
29th Nov 201711:51 amRNSHolding(s) in Company
28th Nov 20177:06 amRNS2017 Bank of England Stress Test Results
23rd Nov 20175:00 pmRNSDividend Declaration
21st Nov 20173:53 pmRNSUpdate on Ring-Fencing Plans
8th Nov 20174:34 pmRNSHolding(s) in Company
8th Nov 20173:28 pmRNSDirector/PDMR Shareholding
8th Nov 20172:40 pmRNSHolding(s) in Company
3rd Nov 201711:55 amRNSHolding(s) in Company
31st Oct 20171:41 pmRNSTotal Voting Rights
27th Oct 20174:17 pmRNSPublication of Suppl.Prospcts
27th Oct 20177:00 amRNSQ3 2017 Interim Management Statement
26th Oct 20172:13 pmRNSHolding(s) in Company
25th Oct 20171:53 pmRNSHolding(s) in Company
24th Oct 20175:37 pmRNSDisposal of shareholdings in Euroclear plc
24th Oct 20171:35 pmRNSHolding(s) in Company
24th Oct 201712:56 pmRNSHolding(s) in Company
20th Oct 201712:03 pmRNSHolding(s) in Company
17th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20175:11 pmRNSNotices of Redemption
5th Oct 201712:24 pmRNSBlock listing Interim Review
29th Sep 20172:39 pmRNSTotal Voting Rights
29th Sep 20171:55 pmRNSThe Royal Bank of Scotland N.V. Interim Results
27th Sep 20176:20 pmRNSAllotment and Issue of New Ordinary Shares
26th Sep 20179:00 amRNSBank of America Merrill Lynch Conference
18th Sep 20175:15 pmRNSEC formally approves Alternative Remedies Package
18th Sep 20171:17 pmRNSHolding(s) in Company
14th Sep 20173:19 pmRNSHolding(s) in Company
11th Sep 20171:30 pmRNSBarclays Global Financial Services Conference
1st Sep 20172:35 pmRNSDirectorate Change
31st Aug 20179:50 amRNSTotal Voting Rights
23rd Aug 20176:11 pmRNSDividend Declaration
7th Aug 20175:43 pmRNSNotice of Redemption
7th Aug 20172:21 pmRNSPublication of Suppl.Prospcts
7th Aug 20177:00 amRNSRedemption of Non-cumulative Dollar Pref. Shares
4th Aug 20174:48 pmRNSRedemption of Non-cumulative Preference Shares
4th Aug 20177:20 amRNSTechnology & Innovation Committee
4th Aug 20177:00 amRNSHalf-year Report
31st Jul 20172:29 pmRNSTotal Voting Rights
26th Jul 20174:31 pmRNSUpdate on RBS's remaining State Aid obligation
12th Jul 20171:34 pmRNSSettlement reached with the FHFA re US RMBS claims
12th Jul 201711:00 amRNSTR-1 Notification of Major Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.